BREAKING NEWS!: FDA Approves Apalutamide (Erleada) for the treatment of metastatic hormone-sensitive prostate cancer. Read More.
Go here to learn more or to get a mailed copy.
Home » Archives for January 2018
Are you a man with advanced or metastatic prostate cancer? Unbeknownst to you, you may have already benefitted from treatments that are the results of the kinds of clinical trials...Read More